This topic contains a solution. Click here to go to the answer

Author Question: Physical beauty confers only limited advantages. Researchers have found that people are MOST likely ... (Read 50 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
Physical beauty confers only limited advantages. Researchers have found that people are MOST likely to associate physical attractiveness with
 
  a. intelligence.
  b. social competence.
  c. integrity.
  d. self-esteem.

Question 2

Research suggests that there is ________ between babies and adults, men and women, and people from several cultures as to what is considered physically attractive.
 
  a. a vast discrepancy
  b. disagreement
  c. amazing consistency
  d. no correlation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

iman

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C




Brittanyd9008

  • Member
  • Posts: 500
Reply 2 on: Jun 22, 2018
Excellent


diana chang

  • Member
  • Posts: 288
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library